Efficacy of Ombitasvir/Paritaprevir/ and Dasabuvir +/-Ribavirin in Patients Receiving Concomitant Acid-Reducing Agents in Phase 3 Trials
Year: 2015
Type: article
Authors: Mitchell Shiffman, Vinod Rustgi, Michael Bennett, Xavier Forns, Tarik Asselah, Ramon Planas Vila, Marcos Pedrosa, Guy Neff, Ronald DʼAmico, Greg Ball, Juan Carlos Lopez-Talavera, Nancy Reau
Institutions: Bon Secours Health System, Bon Secours Liver Institute of Richmond, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Inserm, Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris, Centre de Recherche sur l'Inflammation, Université Paris Diderot, AbbVie (United States), University of Chicago Medical Center
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2599601806